Cancer

Blue Earth Diagnostics Reinforces Leadership in Prostate Cancer Imaging and Highlights Expanding Pipeline at Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2025

BOSTON, June 18, 2025 /PRNewswire/ -- Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of…

6 months ago

New Study Reveals Americans Lost 120 Total Nights of Sleep Over a Five-Year Period, Negatively Impacting Cardiovascular Health, Weight and Longevity

Data from connected health wearables company, Withings, shows how poor sleep impacts cardiovascular risk and longevity across the US –…

6 months ago

Remepy’s Mobile App Shown to Rewire Brain, Modulate Immune System and Improve Mood in Adults with Subjective Cognitive Decline

RMPY-008 is the first app-based intervention to demonstrate rapid modulation of inflammatory blood biomarkers, acting like a digital antibody in…

6 months ago

Intelliseq Integrates Genomenon’s Cancer Knowledgebase (CKB) into iFlow Platform to Advance Somatic Variant Interpretation

ANN ARBOR, Mich. and SAN DIEGO and KRAKÓW, Poland, June 18, 2025 /PRNewswire/ -- Intelliseq, a leader in computational genomics…

6 months ago

PreciseDx Continues Path to Commercial Launch: Secures Additional Funding and Announces New Leadership

Funding now totals over $43 million, strengthened leadership focused on a 2026 commercial launch of the OncoIntelligence™-driven, PreciseBreast™ NEW YORK, June…

6 months ago

Willis Knighton Health Live with 132 Clinics on MEDITECH Expanse

Clinics and hospitals unified on one EHR platform for a single patient record across all facilitiesCANTON, Mass.--(BUSINESS WIRE)--#EHR--Willis Knighton Health…

6 months ago

Akari Therapeutics Bolsters Global IP Estate for its Novel Antibody Drug Conjugate (ADC) Immuno-Oncology Payload, PH1, with Recent Granting of Patent Protection Across India

Differentiated PH1 payload is a spliceosome inhibitor designed to inhibit RNA splicing, leading to cancer cell death and activation of…

6 months ago

Prenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to Board

-  Prenetics adopts proven corporate Bitcoin strategy inspired by MicroStrategy's ~$40B Bitcoin holdings and Metaplanet's meteoric treasury transformation -  Following…

6 months ago

Tevogen Updates on Development of EBV-Specific T Cell Therapy with Support from AI-Powered Target Discovery

WARREN, N.J., June 18, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today provided an…

6 months ago

IMUNON Presents Positive Phase 2 Translational Data of IMNN-001 in Advanced Ovarian Cancer at ESMO Gynaecological Cancers Congress 2025

ASCO 2025 overall survival data bolster IMNN-001’s potential in advanced ovarian cancer, supported by robust translational results at ESMO Results…

6 months ago